Mersana Therapeutics (MRSN) EPS (2017 - 2025)
Mersana Therapeutics (MRSN) EPS from Mar 31, 2017 to Sep 30, 2025. The TTM Mersana Therapeutics (MRSN) EPS is -$14.27. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Mersana Therapeutics (MRSN) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -6.61% |
| 3 Years TTM | -37.62% |
| 5 Years TTM | -15.55% |
| All Time TTM | -13.78% |
Annual EPS change of Mersana Therapeutics (MRSN)
| Year | EPS | Change |
|---|---|---|
| 2025 | -$11.22 | -25.01% |
| 2024 | -$14.96 | -57.93% |
| 2023 | -$35.55 | -26.78% |
| 2022 | -$48.55 | -15.82% |
| 2021 | -$57.68 | +80.41% |
| 2020 | -$31.97 | +105.76% |
| 2019 | -$15.54 | -77.53% |
| 2018 | -$69.14 | +62.65% |
| 2017 | -$42.51 | +301.63% |
| 2016 | -$10.58 | N/A |
Comparison Mersana Therapeutics (MRSN) five years EPS CAGR with competitors
Mersana Therapeutics (MRSN) five years EPS CAGR is -15.54%.